Company intelligence / Profile preview

Barentz

Hoofddorp, Netherlands

Ownership: Private
Employees: ~1100
Development stage: Other

Overview

Barentz does not conduct proprietary clinical trials or develop proprietary drugs; it is a global distributor of specialty ingredients (including APIs, excipients, nutraceuticals) for the pharmaceutical, human and animal nutrition, and personal care sectors, supplying ingredients to manufacturers and offering technical support and formulation services.[1][2][3][4][9]

Modalities: Small moleculeBiologicExcipientsNutraceuticalMedical device component
Industry: Chemicals & Materials

Partnerships

Roquette (strategic distribution partner, especially for pharmaceutical excipients, US and Europe)[4]Ashland (pharma and nutraceuticals, distribution in Europe)[6]

Beyond the preview

Go deeper on Barentz.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Barentz.

Explore the full profile